Showing results (21-30 of 37) with videos related to

Sort By:
Pageof 4
Blood|November 2, 2002
Fludarabine uptake mechanisms in B-cell chronic lymphocytic leukemiaMíriam Molina-Arcas, Beatriz Bellosillo, F Javier Casado, et al.
Haematologica|July 5, 2006
Expression of human equilibrative nucleoside transporter 1 (hENT1) and its correlation with gemcitabine uptake and cytotoxicity in mantle cell lymphomaSilvia Marcé, Míriam Molina-Arcas, Neus Villamor, et al.
Biochemical Pharmacology|July 1, 2008
Adenoviral-mediated overexpression of human equilibrative nucleoside transporter 1 (hENT1) enhances gemcitabine response in human pancreatic cancerSandra Pérez-Torras, José García-Manteiga, Elena Mercadé, et al.
Kidney International|July 15, 2005
Expression of concentrative nucleoside transporters SLC28 (CNT1, CNT2, and CNT3) along the rat nephron: effect of diabetesSílvia Rodríguez-Mulero, Ekaitz Errasti-Murugarren, José Ballarín, et al.
Virus Research|January 15, 2005
Cell entry and export of nucleoside analoguesMarçal Pastor-Anglada, Pedro Cano-Soldado, Míriam Molina-Arcas, et al.
Antiviral Therapy|February 22, 2007
3'-Azido-2',3'-dideoxythymidine (zidovudine) uptake mechanisms in T lymphocytesSergi Purcet, Gerard Minuesa, Míriam Molina-Arcas, et al.
Biochemical Pharmacology|September 13, 2006
Human equilibrative nucleoside transporter-1 (hENT1) is required for the transcriptomic response of the nucleoside-derived drug 5'-DFUR in breast cancer MCF7 cellsMíriam Molina-Arcas, Gema Moreno-Bueno, Pedro Cano-Soldado, et al.
Biochemical Pharmacology|December 7, 2007
Compensatory effects of the human nucleoside transporters on the response to nucleoside-derived drugs in breast cancer MCF7 cellsPedro Cano-Soldado, Míriam Molina-Arcas, Berta Algueró, et al.
Antiviral Therapy|January 18, 2005
Interaction of nucleoside inhibitors of HIV-1 reverse transcriptase with the concentrative nucleoside transporter-1 (SLC28A1)Pedro Cano-Soldado, Ignacio M Lorráyoz, Míriam Molina-Arcas, et al.
International Journal of Cancer|September 24, 2004
Expression of the nucleoside-derived drug transporters hCNT1, hENT1 and hENT2 in gynecologic tumorsXavier Farré, Elena Guillén-Gómez, Lydia Sánchez, et al.
Pageof 4